Philip Ebeling - 10 Feb 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role: Chief Operating Officer
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Philip Ebeling
Issuer symbol: INSP
Transactions as of: 10 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2023, 19:00:19 UTC
Previous filing: 15 Feb 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSP	Common Stock	Gift	$0	-167	-41%	$0.000000	243	18 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INSP	Employee Stock Option (Right to Buy)	Award	$0	+5,450		$0.000000	5,450	10 Feb 2023	Common Stock	5,450	$263.16	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects (a) (i) 167 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "ESPP") on December 31, 2020, (ii) 81 shares acquired under the ESPP on June 30, 2021, (iii) 51 shares acquired under the ESPP on December 31, 2021, (iv) 80 shares acquired under the ESPP on June 30, 2022 and (v) 31 shares acquired under the ESPP on December 31, 2022, minus (b) the 167 shares gifted on November 18, 2022.
F2	The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Content

Reflects (a) (i) 167 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "ESPP") on December 31, 2020, (ii) 81 shares acquired under the ESPP on June 30, 2021, (iii) 51 shares acquired under the ESPP on December 31, 2021, (iv) 80 shares acquired under the ESPP on June 30, 2022 and (v) 31 shares acquired under the ESPP on December 31, 2022, minus (b) the 167 shares gifted on November 18, 2022.

The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.